accountPfizer Inc. Chief Executive Officer Jeffrey Kindler will create smaller business units to help manage the drugmaker after it grows by almost 50 percent as a result of the Wyeth acquisition.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer Future With Wyeth Is Small Units Like J&J, Kindler Says
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account